Medicare Enrolled

Dr. Meri Mehta, MD

Hematology & Oncology · Miramar, FL
1951 SW 172ND AVE STE 313, Miramar, FL 33029
9542654325
Registered in NPPES since 2018
NPI: 1942706916 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mehta

Dr. Meri Mehta is a hematology & oncology specialist in Miramar, FL, with 8 years of NPI registration.

Between the years covered by Open Payments, Dr. Mehta received a total of $5,381 from 25 pharmaceutical and/or device companies across 60 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mehta is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years of NPI registration $5,381 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 149524 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$5,381
Total received (2019-2024)
Avg $897/year across 6 years
Top 47% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
60
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,775
2023
$1,521
2022
$1,335
2021
$472
2020
$17
2019
$262

Payments by company (2024)

PFIZER INC.
$410
AstraZeneca Pharmaceuticals LP
$292
Janssen Scientific Affairs, LLC
$222
Tempus AI, Inc
$200
Coherus Biosciences Inc.
$195
E.R. Squibb & Sons, L.L.C.
$134
SpringWorks Therapeutics, Inc.
$123
Lilly USA, LLC
$108
Genentech USA, Inc.
$46
Legend Biotech USA Inc.
$28
Janssen Biotech, Inc.
$17
Top 3 companies account for 52.0% of 2024 payments
All-time payments by company (2019-2024) ›
AstraZeneca Pharmaceuticals LP
$702
Coherus Biosciences Inc.
$455
E.R. Squibb & Sons, L.L.C.
$451
PFIZER INC.
$410
Genentech USA, Inc.
$371
GENZYME CORPORATION
$293
Amgen Inc.
$270
JAZZ PHARMACEUTICALS INC.
$247
Astellas Pharma US Inc
$235
Janssen Scientific Affairs, LLC
$222
Incyte Corporation
$207
Tempus AI, Inc
$200
Regeneron Healthcare Solutions, Inc.
$192
Jazz Pharmaceuticals Inc.
$173
EMD Serono, Inc.
$125
SpringWorks Therapeutics, Inc.
$123
Blueprint Medicines Corporation
$122
Rigel Pharmaceuticals, Inc.
$121
Eisai Inc.
$108
Lilly USA, LLC
$108
Seagen Inc.
$85
SANOFI-AVENTIS U.S. LLC
$83
Teleflex LLC
$34
Legend Biotech USA Inc.
$28
Janssen Biotech, Inc.
$17
Top 3 companies account for 29.9% of all-time payments
Associated products mentioned in payments ›
ARROW · AYVAKIT · Alecensa · CABLIVI · ELIQUIS · ELITEK · EVENITY · IMFINZI · JAKAFI · Kadcyla · LIBTAYO · LORBRENA · LUMAKRAS · Lenvima · OGSIVEO · OPDIVO · RYBREVANT · TAGRISSO · TEPMETKO · Tavalisse · Tecentriq · Udenyca · VYXEOS · XT CDX · Xospata · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Miramar?
Compare hematology & oncology specialists in the Miramar area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
200
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HOSPITAL MIRAMAR
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mehta is a hematology & oncology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $5,381 from 25 companies across 60 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Miramar
Browse hematology & oncology specialists in Miramar ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Coherus Biosciences Inc. Payments to Doctors
See all physicians who received payments from Coherus Biosciences Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →